NEW YORK (GenomeWeb) – The US Food and Drug Administration has cleared DxnA's GeneSTAT.MDx Coccidioides test for valley fever, the company announced on Wednesday.

The test was cleared to run on the PCR-based GeneSTAT system and is intended for the rapid detection of Coccidioidomycosis. It can provide a definitive diagnosis for both Coccidioides strains that cause the infection and was developed based on intellectual property exclusively licensed from the Translational Genomics Research Institute and the Northern Arizona University.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.